Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
<p>In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.</p>
Bibliographic Details
Main Authors: |
E. V. Kataeva,
A. K. Golenkov,
E. V. Trifonova,
G. A. Dudina,
T. A. Mitina,
L. L. Vysotskaya,
T. D. Lutskaya,
I. V. Buravtsova,
R. V. Gorenkov,
Yu. Yu. Chuksina,
V. V. Yazdovskiy |
Format: | Article
|
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Onkogematologiâ
|
Subjects: |
|
Online Access: | http://oncohematology.abvpress.ru/index.php/ongm/article/view/95
|